What's breaking now, across thousands of outlets.
Armed Cell Therapeutics, chaired by former Galapagos CEO Paul Stoffels, has assumed control of cell therapies the company — now known as Lakefront Biotherapeutics — divested in a strategic overhaul.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
For the first time in more than a quarter-century, Americans have a new option when shopping for sunscreen: a skin-protecting chemical that's long been a go-to option in Europe and other parts of the…
Former FDA commissioners Rob Califf (Obama and Biden administrations), Scott Gottlieb, and Ned Sharpless (both from the first Trump administration) criticized the officials who ran the agency during a…
Illumina is bringing its software, AI, and data offerings together in the new BioInsight platform, designed to help scientists analyze genomic and multiomic datasets.
Mumbai, October 15, 2026: The loose turmeric, chilli powder and garam masala bought by households from neighbourhood grocery stores will now have to be sold in properly packed and sealed form, as the…
(MedPage Today) -- For medium vessel occlusion strokes, perfusion mismatch ratio predicted follow-up infarct volume, a multinational trial showed, supporting a role similar to that in large vessel…
When replacing the aortic valve, a small aortic root can limit the size of the prosthetic valve that can be implanted. If the new valve is too small in relation to the patient's body, the heart must…
